Oregon resident becomes SECOND US woman to die of blood clot after taking J&J vaccine as CDC launches investigation

A SECOND US woman has died of a blood clot shortly after receiving the Johnson & Johnson Covid vaccine, it was revealed on Thursday.

The Oregon Health Authority is working with the Centers for Disease Control and Prevention after a woman developed a "rare but serious blood clot within two weeks following vaccination."

The woman, in her 50s, received the Johnson & Johnson dose before the pause order on its use was issued.

It's too early to tell if the vaccine had caused her death, read a press release from the OHA, which stressed an investigation is still underway.

"This blood clot was seen in combination with very low platelets," the release read.

It added that "cases of this serious blood clot had been identified among six women around the country who received the vaccine," before the pause was put into effect.

Health professionals and medical experts warned that the risk of developing a blood clot due to the Johnson & Johnson vaccine are very low.

"It’s an extraordinarily rare event," said the nation's leading infectious disease expert Dr. Anthony Fauci.

"My estimate is that we will continue to use it in some form. I doubt very seriously if they just cancel it," he said when the vaccine went on pause.

The nation has put the vaccine on pause as experts further investigate how it interacts with the body and its clotting mechanisms.

Over 130 million Americans have received at least one dose of the Covid-19 vaccine, with over 7.8 million receiving the Johnson & Johnson jab.

The CDC and Federal Drug Administration are investigating six reported cases of a rare but severe blood clot called venous sinus thrombosis (CVST).

"Right now, these adverse events appear to be extremely rare," the FDA said in a joint statement with the CDC when it announced the pause of the shot on April 13.

CVST could cause deadly brain hemorrhages in otherwise healthy patients, which was reason for the CDC to pause the vaccine after the first woman passed from one.

Although there is insufficient evidence to link CVST to the jab, medical experts are currently investigating how the six women – all aged between 18 and 48 – developed the condition within one to three weeks after receiving the poke.

The Johnson & Johnson vaccine was paused in the United States last week, just as the European Medicines Agency (EMA) said a warning should be issued with the jab saying unusual blood clots are associated with low levels of blood platelets.

The EMA said this is a rare side effect and as such, side effects are expected with all medications and vaccines, including those for the coronavirus.

Fauci echoed the EMA's results while appearing on NBC's Meet the Press last weekend.

"I do think that there will likely be some sort of warning or restriction or risk assessment. I don’t think it’s just going to go back and say, ‘Okay, everything’s fine. Go right back.’

"I think it’ll likely say, ‘Okay, we’re going to use it, but be careful under these certain circumstances.'

Symptoms of a rare blood clot

Experts at the EMA say that you should seek medical help in the three weeks after receiving the J&J vaccine if you experience any of the following symptoms:

  • shortness of breath
  • chest pain
  • leg swelling
  • persistent abdominal (belly) pain
  • neurological symptoms, such as severe and persistent headaches or blurred vision
  • tiny blood spots under the skin beyond the site of the injection

More to follow…

For the latest news on this story keep checking back at Sun Online.

The Sun is your go to destination for the best celebrity news, football news, real-life stories, jaw-dropping pictures and must-see video.

Download our fantastic, new and improved free App for the best ever Sun Online experience. For iPhone click here, for Android click here

Like us on Facebook at www.facebook.com/TheSunUS and follow us from our main Twitter account at @TheSunUS.

    Source: Read Full Article